OncoSec Medical Inc
OTC:ONCSQ
Cash Flow Statement
Cash Flow Statement
OncoSec Medical Inc
| Jul-2020 | Jul-2021 | Jul-2022 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
(42)
|
(45)
|
(34)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
|
| Stock-Based Compensation |
4
|
5
|
2
|
|
| Other Non-Cash Items |
5
|
6
|
3
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
|
| Change in Working Capital |
4
|
(2)
|
(1)
|
|
| Cash from Operating Activities |
(33)
N/A
|
(42)
-26%
|
(32)
+23%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
0
|
(1)
|
(0)
|
|
| Cash from Investing Activities |
0
N/A
|
(1)
N/A
|
(0)
+69%
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
30
|
68
|
0
|
|
| Net Issuance of Debt |
1
|
(1)
|
(1)
|
|
| Other |
(2)
|
1
|
(0)
|
|
| Cash from Financing Activities |
28
N/A
|
68
+140%
|
(1)
N/A
|
|
| Change in Cash | ||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
(0)
|
|
| Net Change in Cash |
(5)
N/A
|
26
N/A
|
(34)
N/A
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(33)
N/A
|
(43)
-29%
|
(32)
+24%
|
|